Maria D Donovan
Overview
Explore the profile of Maria D Donovan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heinrich C, McHugh S, McCarthy S, Curran G, Donovan M
Res Social Adm Pharm
. 2023 May;
19(8):1202-1213.
PMID: 37230873
Introduction: Deprescribing is a strategy for reducing the use of potentially inappropriate medications for older adults. Limited evidence exists on the development of strategies to support healthcare professionals (HCPs) deprescribing...
2.
Heinrich C, McHugh S, McCarthy S, Donovan M
PLoS One
. 2022 Dec;
17(12):e0274552.
PMID: 36520798
Introduction: The prevalence of polypharmacy increases with age, increasing the exposure of older adults to potentially inappropriate medications (PIMs). Deprescribing has been shown to reduce PIMs for older residents in...
3.
Heinrich C, McCarthy S, McHugh S, Donovan M
Drugs Real World Outcomes
. 2022 Nov;
10(1):97-106.
PMID: 36436174
Introduction: Deprescribing is associated with positive health outcomes for older adults in long-term care (LTC), however deprescribing is not universally implemented. Objective: The primary aim of this study was to...
4.
Heinrich C, Hurley E, McCarthy S, McHugh S, Donovan M
Age Ageing
. 2022 Jan;
51(1).
PMID: 35077555
Introduction: older adults are at risk of adverse outcomes due to a high prevalence of polypharmacy and potentially inappropriate medications (PIMs). Deprescribing interventions have been demonstrated to reduce polypharmacy and...
5.
Heinrich C, Donovan M
Int J Pharm Pract
. 2022 Jan;
30(1):28-35.
PMID: 34998277
Objectives: The main objective of this study was to assess community pharmacists' thoughts regarding the role they can play in effectively integrating deprescribing into clinical practice in Ireland. The aim...
6.
Kelleher J, Weedle P, Donovan M
Pharmacy (Basel)
. 2021 Oct;
9(4).
PMID: 34698248
Background: Antipsychotic medications are often used 'off-licence' to treat neuropsychiatric symptoms and disorders of aging and to manage behavioural and psychological symptoms of dementia despite the warnings of adverse effects....
7.
Donovan M, Byrne E, Griffin B
Curr Pharm Teach Learn
. 2020 Jun;
12(8):901-909.
PMID: 32564991
Introduction: Recently, the model of pharmacy education in Ireland changed to a five-year pharmacy degree, with three distinct blocks of experimental placements dispersed throughout the degree. The United Kingdom is...
8.
Donovan M, Abduljalil K, Cryan J, Boylan G, Griffin B
Biopharm Drug Dispos
. 2018 Jan;
39(3):125-134.
PMID: 29319897
Bumetanide is a loop diuretic that is proposed to possess a beneficial effect on disorders of the central nervous system, including neonatal seizures. Therefore, prediction of unbound bumetanide concentrations in...
9.
Griffin B, Guo J, Presas E, Donovan M, Alonso M, ODriscoll C
Adv Drug Deliv Rev
. 2016 Jun;
106(Pt B):367-380.
PMID: 27320644
The influence of nanoparticle (NP) formulations on the pharmacokinetic, pharmacodynamic and biodistribution profiles of peptide- and protein-like drugs following oral administration is critically reviewed. The possible mechanisms of absorption enhancement...
10.
Donovan M, Griffin B, Kharoshankaya L, Cryan J, Boylan G
Drugs
. 2016 Mar;
76(6):647-61.
PMID: 26943929
Seizures are the most common neurological emergencies in the neonatal period and are associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 term births and population-based studies...